Stockscreener 앱 받기
1.56
3.11%
-0.05
시간 외 거래:
1.62
0.06
+3.85%
전일 마감가:
$1.61
열려 있는:
$1.66
하루 거래량:
128.49K
Relative Volume:
0.02
시가총액:
$5.11M
수익:
$1.31M
순이익/손실:
$-7.47M
주가수익비율:
-0.2163
EPS:
-7.2117
순현금흐름:
$-5.11M
1주 성능:
-20.41%
1개월 성능:
-36.84%
6개월 성능:
+414.85%
1년 성능:
+579.15%
1일 변동 폭
$1.54
$1.71
1주일 범위
$1.54
$2.015
52주 변동 폭
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
SPRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
1.56 | 5.27M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scisparc Ltd 주식(SPRC)의 최신 뉴스
What analysts say about SciSparc Ltd stockStop Loss Placement Tips & Rapid Profit Portfolio - earlytimes.in
SciSparc Ltd. Announces $2.2 Million Securities Offering - MSN
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc gets Nasdaq extension to regain compliance - MSN
Scisparc Ltd (SPRC) - MSN
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - MSN
SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast - ts2.tech
Will SciSparc Ltd. stock outperform growth indexesJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
NeuroThera to acquire 55% stake in quantum computing bio data company - MSN
SciSparc Shares Slide After Revealing Plans to Acquire MUSE Endoscopic System IP - MSN
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition - TipRanks
SciSparc Ltd. Announces NeuroThera Labs' Planned Acquisition of Quantum Computing Bio Data Company - Quiver Quantitative
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company - The Manila Times
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to - GlobeNewswire
SciSparc plans to enter GERD device market with IP portfolio acquisition - MSN
symbol__ Stock Quote Price and Forecast - CNN
SciSparc (SPRC) Stock Analysis Report | Financials & Insights - Benzinga
SciSparc stock tumbles after announcing MUSE system acquisition plans By Investing.com - Investing.com UK
SciSparc Ltd. (SPRC) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
SciSparc stock tumbles after announcing MUSE system acquisition plans - Investing.com
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com Nigeria
SciSparc to acquire MUSE endoscopic system patents from Xylo - Investing.com
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio - The Manila Times
Scisparc plans on entering the multi-billion-dollar GERD device market with acquisition of an approved IP portfolio - marketscreener.com
SciSparc Ltd. Signs Agreement to Acquire Patents and Intellectual Property for Innovative MUSE™ Endoscopic System from Xylo Technologies Ltd. - Quiver Quantitative
Scisparc Plans On Entering The Multi-Billion-Dollar Gerd Device Market With Acquisition Of An Approved IP Portfolio - TradingView
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio - Indian Pharma Post
SciSparc Ltd. (SPRC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
SciSparc to acquire treasury of patents for medical endoscopy systems - MSN
Form 424B5 SciSparc Ltd. - StreetInsider
Is SciSparc Ltd a good long term investmentStock Buyback Announcements & Free Tap Rapid Wealth - earlytimes.in
SciSparc Shares Surge After Company Moves to Acquire GERD Treatment Technology - MSN
SciSparc stock soars after acquiring GERD treatment technology By Investing.com - Investing.com Australia
SciSparc’s Stock Slip: Investment Opportunity? - timothysykes.com
SciSparc Ltd. to Acquire Xylo’s Patents for Endoscopic Systems - TipRanks
[6-K] SciSparc Ltd. Current Report (Foreign Issuer) | SPRC SEC FilingForm 6-K - Stock Titan
SciSparc’s Patent Surge: Buy or Hold? - StocksToTrade
SciSparc Ltd. (SPRC) Stock: Jumps as Company Expands into High-Growth GERD Device Market - parameter.io
Why SciSparc Stock Is Gaining TodaySciSparc (NASDAQ:SPRC) - Benzinga
SciSparc to acquire endoscopic system patents from Xylo Technologies By Investing.com - Investing.com Nigeria
Scisparc Ltd (SPRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):